title: Valacyclovir for the prevention of cytomegalovirus infection after kidney transplantation is associated with macrocytosis.
authors.forename: Julien
authors.initials: J
authors.lastname: Baud
authors.forename: Wael
authors.initials: W
authors.lastname: El Haggan
authors.forename: Dina
authors.initials: D
authors.lastname: Naguib
authors.forename: Xavier
authors.initials: X
authors.lastname: Troussard
authors.forename: Bruno
authors.initials: B
authors.lastname: Hurault de Ligny
mesh_terms: D000212:Acyclovir / Q000009:adverse effects* / Q000031:analogs & derivatives*; D000998:Antiviral Agents / Q000009:adverse effects*; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D004909:Erythrocyte Indices; D004913:Erythrocytes, Abnormal; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D000077483:Valacyclovir; D014633:Valine / Q000009:adverse effects* / Q000031:analogs & derivatives*
chemical_list: D000998:Antiviral Agents; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir